← Back to Search

Decision Coaching for Lung Cancer Screening

N/A
Recruiting
Led By Anita Y Kinney, PhD, RN
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants completing the semi-structured interviews must be age 18 or older
Participants completing the semi-structured interviews must be fluent in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the change in baseline, three months and five years
Awards & highlights

Study Summary

This trial is testing whether navigator decision coaching, compared to enhanced usual care, results in better decision making for lung cancer screening, more screenings, and increased adherence to repeat screenings and diagnostic testing. A booster coaching session is also being tested to see if it increases adherence to repeat screenings.

Who is the study for?
The TELESCOPE trial is for English-speaking adults aged 50-77 who have a significant smoking history (at least 20 pack-years) and are either current smokers or quit within the last 15 years. They must be due for a non-emergency medical visit but not pregnant, without lung cancer history, nor screened for it in the past year. Health providers involved need to work at participating sites.Check my eligibility
What is being tested?
This study tests if remote decision coaching with navigation intervention (TELESCOPE) improves shared decision-making in lung cancer screening compared to usual care. It aims to increase knowledge about screening, encourage more discussions, and boost adherence to repeat screenings and smoking cessation referrals.See study design
What are the potential side effects?
Since this trial involves decision coaching rather than medication or invasive procedures, traditional side effects are not expected. However, participants may experience psychological impacts from increased awareness of their health status.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am fluent in English.
Select...
I am between 50 and 77 years old.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the change in baseline, three months and five years
This trial's timeline: 3 weeks for screening, Varies for treatment, and the change in baseline, three months and five years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To assess shared decision making
Secondary outcome measures
Tobacco treatment referral
Other outcome measures
Completion of diagnostic testing
Receipt of tobacco treatment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TELESCOPE interventionExperimental Treatment1 Intervention
Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. If a participant is a current smoker then they are offered and navigated to evidence-based smoking cessation. If the participant is interested in screening, an LDCT is ordered. Support for screening, diagnostic testing and oncology care will be provided as needed from the Nurse Navigators.
Group II: Enhanced usual care (EUC)Active Control1 Intervention
Participants will be surveyed at baseline and at one-week after the scheduled primary care office visit. Primary and secondary outcome data related to the office visit will be collected.

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,685 Previous Clinical Trials
6,930,376 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,820 Previous Clinical Trials
47,299,017 Total Patients Enrolled
Rutgers, The State University of New JerseyLead Sponsor
426 Previous Clinical Trials
63,725 Total Patients Enrolled

Media Library

Remote Decision Coaching with Navigation Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05491213 — N/A
Lung Cancer Research Study Groups: TELESCOPE intervention, Enhanced usual care (EUC)
Lung Cancer Clinical Trial 2023: Remote Decision Coaching with Navigation Intervention Highlights & Side Effects. Trial Name: NCT05491213 — N/A
Remote Decision Coaching with Navigation Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05491213 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively recruiting participants?

"According to information hosted on clinicaltrials.gov, this specific medical trial is not currently enrolling patients. The study was first posted on February 28th 2023 and the last update occured October 31st 2022. Despite this, there are still 1496 active trials searching for participants at present."

Answered by AI
~280 spots leftby Dec 2026